K. Jellinger

K. Jellinger, P. Fasching, J. Spatt, 2010, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases

K. Jellinger, C. Lucchinetti, W. Brück, 2003, Journal of neuropathology and experimental neurology.

Morphological differences between the two major subtypes of multiple system atrophy with cognitive impairment.

K. Jellinger, 2022, Parkinsonism & related disorders.

Levodopa in the treatment of (PRE) senile dementia

K. Jellinger, P. Riederer, L. Ambrozi, 1980, Mechanisms of Ageing and Development.

[Fatal encephalitis after poliomyelitis vaccination].

K. Jellinger, C. Kunz, H. Zischinsky, 1961, Klinische Wochenschrift.

An Introduction to the Mathematics of Neurons, 2nd Edn

K. Jellinger, 1998 .

Dear Sir:

K. Jellinger, W. Paulus, 2005, Journal of Neuro-Oncology.

Sex and Longevity: Sexuality, Gender, Reproduction, Parenthood

K. Jellinger, 2002 .

The Confabulating Mind How the brain creates reality

K. Jellinger, 2009 .

CNS AND ADRENAL GLAND TYROSINE HYDROXYLASE AND THE INFLUENCE OF DRUG TREATMENT ON cAMP - ACTIVITY IN PARKINSON'S DISEASE - HUMAN POST MORTEM STUDIES

K. Jellinger, P. Riederer, W. Danielczyk, 1979 .

DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS

K. Jellinger, G. Reynolds, P. Riederer, 1980, The Lancet.

Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients

K. Jellinger, H. Braak, P. Fischer, 1993, Neuroscience Letters.

Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome.

K. Jellinger, P. Riederer, T. Tatschner, 2000, Neuroscience letters.

Pathomechanisms of depression in multiple system atrophy

K. Jellinger, 2022, Journal of Neural Transmission.

Malingering and Illness Deception

K. Jellinger, 2004 .

A Textbook of Clinical Neurology

K. Jellinger, K. A. Jellinger, 1928, The Indian Medical Gazette.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Linda J. C. van Waalwijk van Doorn, K. Jellinger, A. Fagan, 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Memory and Brain Dynamics Oscillations Integrating Attention, Perception, Learning, and Memory

K. Jellinger, K. A. Jellinger, 2005 .

Brain Death and the Vegetative State

K. Jellinger, 2010 .

Cerebral blood flow and brain stem lesion

K. Jellinger, W. Heiss, 1972, Zeitschrift für Neurologie.

Cell death mechanisms in Parkinson's disease

K. Jellinger, 2000, Journal of Neural Transmission.

Ageing and Dementia

K. Jellinger, F. Fazekas, M. Windisch, 1998, Journal of Neural Transmission. Supplementa.

Pathobiological Subtypes of Alzheimer Disease

K. Jellinger, 2021, Dementia and Geriatric Cognitive Disorders.

Cancer in the nervous system, 2nd edition

K. Jellinger, 2002 .

Comparison of benzodiazepine receptor binding in membranes from human or rat brain

K. Jellinger, P. Riederer, W. Sieghart, 1985, Neuropharmacology.

New Trends in the Diagnosis and Therapy of Alzheimer’s Disease

K. Jellinger, G. Ladurner, M. Windisch, 1994, Key Topics in Brain Research.

Neuropathology of the Alzheimer's continuum: an update.

K. Jellinger, 2020, Free neuropathology.

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

K. Jellinger, L. Frölich, P. Riederer, 1998, Journal of Neural Transmission.

Had Adolf Hitler post-encephalitic parkinsonism?

K. Jellinger, 1996, Parkinsonism & related disorders.

Rhodium Catalysed Hydroformylation

K. Jellinger, 2003 .

Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)

K. Jellinger, P. Riederer, 1983, Acta neurologica Scandinavica. Supplementum.

Handbook of Drug Interactions: A Clinical and Forensic Guide

K. Jellinger, 2004 .

The GABA Receptors. Third edition

K. Jellinger, 2009 .

Brain Monoamines in Cerebral Infarction and Coma

K. Jellinger, P. Riederer, 1979 .

Inborn Metabolic Diseases Diagnosis and Treatment, 5th edn Jean‐Marie Saudubray, Georges Van den Berghe, Walter John H. (eds). Berlin‐Heidelberg: Springer, 2012, hardcover, 656 pp., Price: € 159.95, US$ 209.00, ISBN 978‐3‐642‐15719‐6.

K. Jellinger, 2012 .

Pathologic Effects of Chemotherapy

K. Jellinger, 1983 .

Central nervous system and skeletal muscle involvement in systemic candidiasis

K. Jellinger, H. Bankl, K. A. Jellinger, 2004, Acta Neuropathologica.

Forensic Neuropathology and Associated Neurology

Hans Günter König, Roland N. Auer, K. Jellinger, 2009 .

Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases.

K. Jellinger, 2001, Journal of neuropathology and experimental neurology.

Primary central nervous system lymphomas—an update

K. Jellinger, W. Paulus, 2005, Journal of Cancer Research and Clinical Oncology.

Metastasis of solid tumors in extraocular muscles

K. Jellinger, W. Grisold, M. Vesely, 2004, Acta Neuropathologica.

Neuropathology and general autopsy findings in AIDS during the last 15 years

K. Jellinger, G. Böhm, F. Lintner, 2000, Acta Neuropathologica.

Interaction between α-Synuclein and Other Proteins in Neurodegenerative Disorders

K. Jellinger, 2011, TheScientificWorldJournal.

Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis

K. Jellinger, P. Riederer, E. Kienzl, 1992, Journal of neurochemistry.

Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease.

K. Jellinger, M. Youdim, K. Jellinger, 1996, Biochimica et biophysica acta.

The role of transition metals in the pathogenesis of Parkinson's disease

K. Jellinger, W. Linert, E. Kienzl, 1995, Journal of the Neurological Sciences.

Kynurenine metabolism in Alzheimer's disease

K. Jellinger, L. Deecke, H. Baran, 1999, Journal of Neural Transmission.

Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain

K. Jellinger, P. Riederer, K. Kiuchi, 2005, Journal of Neural Transmission.

Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

K. Jellinger, W. Brück, H. Lassmann, 1999, The American journal of pathology.

[Cerebral lesions in congenital nonhemolytic jaundice (Crigler-Najjar syndrome)].

K. Jellinger, G. Weißenbacher, M. Minauf, 1970, Acta neuropathologica.

Brain quinolinic acid in Alzheimer's dementia

K. Jellinger, P. Riederer, J. Halket, 2005, European archives of psychiatry and neurological sciences.

Brain monoamines in hepatic encephalopathy and other types of metabolic coma.

K. Jellinger, P. Riederer, W. Rausch, 1978, Journal of neural transmission. Supplementum.

Transitional states of central serotonin receptors in Parkinson's disease

K. Jellinger, P. Riederer, E. Kienzl, 2005, Journal of Neural Transmission.

Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease

K. Jellinger, P. Riederer, E. Sofić, 1992, Annals of neurology.

Melanotic paraganglioma of the orbit: a case report

K. Jellinger, W. Paulus, H. Brenner, 2004, Acta Neuropathologica.

Pathology of Parkinson’s Syndrome

K. Jellinger, 1989 .

Olfactory involvement in aging and Alzheimer's disease: an autopsy study.

K. Jellinger, J. Attems, F. Lintner, 2005, Journal of Alzheimer's disease : JAD.

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.

P Riederer, K. Jellinger, G. Reynolds, 1987, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Bimodal distribution of dopamine receptor densities in brains of schizophrenics.

P Riederer, K. Jellinger, G. Reynolds, 1984, Science.

New Possibilites for Early Diagnosis of Alzheimer Disease: "Alzheimer Associated Gene" and Blood Biomarkers Nowe możliwości sprzyjające wczesnemu rozpoznawaniu choroby Alzheimera: "Alzheimer Associated Gene" i biomarkery krwi

K. Jellinger, 2007 .

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.

K. Jellinger, K A Jellinger, 1991, Molecular and chemical neuropathology.

How to run a brain bank: A report from the Austro-German brain bank

K. Jellinger, S. Heckers, H. Heinsen, 1993 .

Morphological substrates of dementia in parkinsonism. A critical update.

K. Jellinger, 1997, Journal of neural transmission. Supplementum.

Circulating antineuronal antibodies reach neurons in vivo: an autopsy study

K. Jellinger, F. Lintner, W. Grisold, 1992, Journal of Neurology.

Perivascular accumulation of lipids in the infant human brain

K. Jellinger, F. Seitelberger, M. Kozik, 2004, Acta Neuropathologica.

[Embryonal carcinoma of the pineal region].

K. Jellinger, M. Minauf, H. Kraus, 1970, Acta neuropathologica.

[Neuropathology of brain tumors in childhood].

K. Jellinger, F. Seitelberger, 1970, Wiener medizinische Wochenschrift.

The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease

K. Jellinger, J. Attems, 2008, Neuropathology and applied neurobiology.

Prevalence and pathology of vascular dementia in the oldest-old.

K. Jellinger, J. Attems, 2010, Journal of Alzheimer's disease : JAD.

Human brain dopamine receptors in children and aging adults

Philip Seeman, Peter Riederer, Kurt Jellinger, 1987, Synapse.

Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathy.

K. Jellinger, P. Riederer, P. Ferenci, 2008, Liver.

Oral and parenteral nutrition with L-Valine: mode of action.

K. Jellinger, P. Riederer, M. Weiser, 1980, Nutrition and metabolism.

Brain Edema as a Neurological Problem—I

K. Jellinger, H. Hoff, 1967 .

Plum and Posner’s – Diagnosis of Stupor and Coma, Fourth Edition

K. Jellinger, S. Gilman, M. Aldrich, 2009 .

TNFα inhibitors as targets for protective therapies in MSA: a viewpoint

K. Jellinger, G. Wenning, T. Berger, 2019, Journal of neuroinflammation.

The pathology of Parkinson's disease.

K. Jellinger, K A Jellinger, 2001, Advances in neurology.

Neuropathological aspects of infantile spasms

K. Jellinger, 1987, Brain and Development.

Olfactory bulb involvement in neurodegenerative diseases

K. Jellinger, J. Attems, L. Walker, 2014, Acta Neuropathologica.

The diabetic brain and cognition

K. Jellinger, M. Kamal, M. Chopp, 2017, Journal of Neural Transmission.

Giant-cell glioblastoma of the thoracic cord

K. Jellinger, W. Grisold, G. Pernetzky, 2005, Acta Neurochirurgica.

Morphological Backgrounds of Pathochemical Studies in Major Psychoses

K. Jellinger, 1985 .

The Neuronal Ceroid Lipofuscinosis (Batten Disease)

K. Jellinger, 1999 .

Chapter 1 – Advances in our Understanding of Neurodegeneration

K. Jellinger, 2007 .

Recent advances in our understanding of neurodegeneration

K. Jellinger, 2009, Journal of Neural Transmission.

Advances in Dementia Research

K. Jellinger, R. Schmidt, M. Windisch, 2000, Springer Vienna.

The relevance of metals in the pathophysiology of neurodegeneration, pathological considerations.

K. Jellinger, 2013, International review of neurobiology.

Fatal Graft-versus-Host reaction following granulocyte transfusions

K. Jellinger, P. Höcker, W. Gebhart, 1982, Blut.

Human neurolymphomatosis in a patient with chronic lymphatic leukemia.

K. Jellinger, W. Grisold, D. Lutz, 1990, Clinical neuropathology.

Neuropathology of Movement Disorders

K. Jellinger, 1998 .

The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2‐BETA1 changes in sporadic Alzheimer's disease

K. Jellinger, D. Rujescu, H. Möller, 2006, Journal of neurochemistry.

[Results of combined modality treatment of malignant gliomas. Comparison of postoperative irradiation, chemotherapy, and combined radio-polychemotherapy (author's transl)].

K. Jellinger, I. Podreka, W. Grisold, 1981, Der Nervenarzt.

[Fibrocartilaginous embolism of the spinal cord].

K. Jellinger, 2006, Der Nervenarzt.

Involvement of the central nervous system in malignant lymphomas

K. Jellinger, T. Radaszkiewicz, 1976, Virchows Archiv A.

Frontiers in Clinical Drug Research - Alzheimer Disorders

K. Jellinger, J. O'Donnell, M. Crespo-Alonso, 2015 .

The Role of Iron in Neurodegeneration

K. Jellinger, Kurt A. Jellinger, 1999, Drugs & aging.

Thomas Wisniewski, Radoslav Matej, Colin Smith, 2015, Acta Neuropathologica.

Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases.

K. Jellinger, J. Attems, F. Lintner, 2005, Journal of Alzheimer's disease : JAD.

L-dopa response pattern in a rat model of mild striatonigral degeneration

K. Jellinger, G. Wenning, N. Stefanova, 2019, PloS one.

Intimal cushions in ciliary arteries of the dog

K. Jellinger, 1974, Experientia.

Lewy Body Disorders

K. Jellinger, 2007 .

General aspects of neurodegeneration.

K. Jellinger, 2003, Journal of neural transmission. Supplementum.

Ageing and Dementia Current and Future Concepts

K. Jellinger, R. Schmidt, M. Windisch, 2002, Journal of Neural Transmission. Supplementa.

Amygdala pathology in Parkinson's disease

Kurt Jellinger, K. Jellinger, H. Braak, 2004, Acta Neuropathologica.

Minds Behind the Brain. A History of the Pioneers and their Discoveries

K. Jellinger, K. A. Jellinger, 2006 .

The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease

K. Jellinger, W. Paulus, 1991, Journal of neuropathology and experimental neurology.

Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease

H A Kestler, L Lausser, K. Jellinger, 2012, Neurology.

Alzheimer’s disease: a challenge for modern neuropathobiology

K. Jellinger, 2009, Acta Neuropathologica.

Juvenile form of spongy degeneration of the CNS

K. Jellinger, F. Seitelberger, K. Jellinger, 2004, Acta Neuropathologica.

Review: Sporadic cerebral amyloid angiopathy

K. Jellinger, J. Attems, W. V. Van Nostrand, 2011, Neuropathology and applied neurobiology.

Cerebrospinal Fluid in Clinical Practice

K. Jellinger, 2009 .

Aids to the Examination of the Peripheral Nervous System

K. Jellinger, Kurt A. Jellinger, 2001 .

Testing for prion protein does not confirm previously reported conjugal CJD

K. Jellinger, H. Budka, J. Hainfellner, 1996, The Lancet.

Aging and Age-Related Disorders

K. Jellinger, 2011 .

Pathology of Parkinsonism

K. Jellinger, 2000, Neurobiology of Aging.

Alterations of muscarinic acetylcholine receptor subypes in diffuse Lewy body disease: relation to Alzheimer's disease

K. Jellinger, 2000, Journal of neurology, neurosurgery, and psychiatry.

Cholinergic and monoaminergic neuromediator systems in DAT. Neuropathological and neurochemical findings

K. Jellinger, P. Riederer, W. Gsell, 1990 .

Reflection of changes in membrane constituents in various regions of Alzheimer brains to differential scanning thermograms.

K. Jellinger, S. Heckers, L. Frölich, 1990, Journal of neural transmission. Supplementum.

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

K. Jellinger, J. Kornhuber, P. Riederer, 1995, Neuropharmacology.

Update on Alzheimer’s Disease

K. Jellinger, 2015, EMJ Neurology.

[Spring-summer encephalomyelitis in middle Europe. (Report on verified observations from the epidemics in Austria)].

K. Jellinger, F. Seitelberger, 1960, Der Nervenarzt.

Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infection

K. Jellinger, K. Zwiauer, T. Popow-Kraupp, 1995, The Lancet.

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint

K. Jellinger, G. Wenning, N. Stefanova, 2018, Journal of Alzheimer's disease : JAD.

The relationship between subcortical tau pathology and Alzheimer's disease.

K. Jellinger, J. Attems, D. Thal, 2012, Biochemical Society transactions.

Relapsing form of subacute necrotizing encephalomyelopathy.

K. Jellinger, D. Müller, H. Zimprich, 1973, Neuropatologia polska.

More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains

K. Jellinger, 2007, Acta Neuropathologica.

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy

K. Jellinger, 2017, Journal of Alzheimer's disease : JAD.

Post-mortem assessment in vascular dementia: advances and aspirations

K. Jellinger, T. Hortobágyi, J. Attems, 2016, BMC Medicine.

Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?

K. Jellinger, A. Korczyn, 2018, BMC Medicine.

Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

K. Jellinger, J. Attems, D. Mann, 2014, American journal of neurodegenerative disease.

[Early summer meningoencephalitis vaccination].

K. Jellinger, 1992, Deutsche medizinische Wochenschrift.

Intracerebral fibroma in an 11-month-old infant. Case report.

K. Jellinger, W. Koos, M. Sunder-Plassmann, 1971, Journal of neurosurgery.

Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study

K. Jellinger, J. Jankovic, Y. Agid, 1998, European journal of neurology.

Olfaction and Aging: A Mini-Review

K. Jellinger, J. Attems, L. Walker, 2015, Gerontology.

Neuropathological approaches to cerebral aging and neuroplasticity

K. Jellinger, J. Attems, 2013, Dialogues in clinical neuroscience.

Recent update on the heterogeneity of the Alzheimer’s disease spectrum

K. Jellinger, 2021, Journal of Neural Transmission.

Mechanisms of cell death in neurodegenerative disorders.

K. Jellinger, C. Stadelmann, 2000, Journal of neural transmission. Supplementum.

Subacute necrotizing encephalomyelopathy (LEIGH).

K. Jellinger, F. Seitelberger, 1970, Ergebnisse der inneren Medizin und Kinderheilkunde.

A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome

K. Jellinger, J. Kornhuber, P. Riederer, 1996, Brain Research.

Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.

K. Jellinger, J. Attems, K A Jellinger, 2006, Clinical neuropathology.

Morphological changes in anaplastic gliomas treated with radiation and chemotherapy

K. Jellinger, W. Heiss, L. Gerstner, 2005, Acta Neurochirurgica.

Glioblastoma multiforme: Morphology and biology

K. Jellinger, K. Jellinger, 2005, Acta Neurochirurgica.

Blood group isoantigens in angioblastic meningiomas and hemangioblastomas of the central nervous system

K. Jellinger, H. Denk, 2005, Virchows Archiv A.

Intrathecal levels of IL-6 in Alzheimer’s disease

K. Jellinger, 2009, Journal of Neurology.

Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease

K. Jellinger, P. Riederer, F. Leblhuber, 2006, Neurochemistry International.

Interaction between pathogenic proteins in neurodegenerative disorders

K. Jellinger, B. Popescu, 2012, Journal of cellular and molecular medicine.

The Morphology of Centrally-situated Angiomas

K. Jellinger, 1975 .

Short Communication Activation of Caspase-3 in Single Neurons and Autophagic Granules of Granulovacuolar Degeneration in Alzheimer's Disease Evidence for Apoptotic Cell Death

K. Jellinger, H. Lassmann, C. Stadelmann, 1999 .

IRS 2 Insulin receptor substrate-2

K. Jellinger, M. Kamal, M. Chopp, 2017 .

Detection of glycosaminoglycans in human gliomas by histochemical methods.

K. Jellinger, P. Böck, 1981, Acta neuropathologica. Supplementum.

Mechanisms of cell death in Alzheimer's disease.

K. Jellinger, H. Lassmann, C. Bancher, 1997, Journal of neural transmission. Supplementum.

Apoptosis vs Nonapoptotic Mechanisms in Neurodegeneration

K. Jellinger, 2003 .

Problems of cell death in neurodegeneration and Alzheimer's Disease.

K. Jellinger, C. Stadelmann, 2001, Journal of Alzheimer's disease : JAD.

Is there apoptosis in Lewy body disease?

K. Jellinger, 1999, Acta Neuropathologica.

Pathology of civilization diseases: J. Sós, T. Gáti, L. Csalay and I. Dési (editors). (Akademiai Kiadó, Budapest, 1971, 172 p., $6.00).

K. Jellinger, 1975 .

Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts

K. Jellinger, G. Wenning, N. Stefanova, 2011, Acta Neuropathologica.

Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas

K. Jellinger, D. Volc, R. Vollmer, 2005, Acta Neurochirurgica.

Russell & Rubinstein's Pathology of Tumors of the Nervous System

K. Jellinger, 2007 .

Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease

K. Jellinger, H. Budka, J. Hainfellner, 1998, Acta Neuropathologica.

Neuropathology of Dementia Disorders

K. Jellinger, 2014 .

Challenges in the Neuropathological Diagnosis of Dementias

K. Jellinger, 2013 .

Neuropathological spectrum of synucleinopathies

K. Jellinger, Kurt A Jellinger, 2003, Movement disorders : official journal of the Movement Disorder Society.

Heterogeneity of Multiple System Atrophy: An Update

K. Jellinger, 2022, Biomedicines.

Neuropathology of multiple system atrophy: New thoughts about pathogenesis

K. Jellinger, 2014, Movement disorders : official journal of the Movement Disorder Society.

Grading of neuropathology in multiple system atrophy: Proposal for a novel scale

Klaus Seppi, K. Jellinger, K. Seppi, 2005, Movement disorders : official journal of the Movement Disorder Society.

The ataxic (cerebellar) form of creutzfeldt-jakob disease

K. Jellinger, W. Heiss, E. Deisenhammer, 2004, Journal of Neurology.

Extracranial metastases of anaplastic cerebral gliomas

K. Jellinger, H. Schuster, H. Regele, 2005, Acta Neurochirurgica.

Cytomegalovirus infection of the brain in AIDS: a clinicopathological study

K. Jellinger, F. Lintner, W. Grisold, 2004, Acta Neuropathologica.

K.K. Jain, Drug‐induced neurological disorders

K. Jellinger, 1996 .

Nuclear inclusions in subacute spongiform encephalopathy

K. Jellinger, 2004, Acta Neuropathologica.

The Treatment of Epilepsy. Principles & Practice

K. Jellinger, K. A. Jellinger, 2001 .

No tissue damage by chronic deep brain stimulation in Parkinson's disease

Christine Haberler, Peter Pilz, Herbert Budka, 2000, Annals of neurology.

The morphological substrate of memory impairment in multiple system atrophy

K. Jellinger, 2022, Neuropathology and applied neurobiology.

Animal models of synucleinopathies and how they could impact future drug discovery and delivery efforts

K. Jellinger, 2019, Expert opinion on drug discovery.

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders

K. Jellinger, 2019, Journal of Neural Transmission.

Protracted post-traumatic encephalopathy. Pathology, pathogenesis and clinical implications.

K. Jellinger, F. Seitelberger, K. A. Jellinger, 1970, Journal of the neurological sciences.

Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research

K. Jellinger, T. Crow, G. Reynolds, 1995, Journal of Neural Transmission / General Section JNT.

No increased incidence of Alzheimer’s disease in elderly schizophrenics

K. Jellinger, E. Gabriel, 1999, Acta Neuropathologica.

NEUROENDOCRINE CHANGES AND ALZHEIMER DISEASE IN POSTMENOPAUSAL WOMEN

K. Jellinger, 2015 .

Head injury and dementia

K. Jellinger, 2004, Current opinion in neurology.

Oligodendroglioma with extraneural metastases.

K. Jellinger, M. Salzer-Kuntschik, M. Minauf, 1969, Journal of neurology, neurosurgery, and psychiatry.

Oligodendroglioma withextraneural metastases

K. Jellinger, M. Salzer-Kuntschik, M. Minauf, 1969 .

Spongy glio-neuronal dystrophy in infancy and childhood

K. Jellinger, F. Seitelberger, 2004, Acta Neuropathologica.

[Subacute spongiform encephalopathy (Jakob-Cretzfeldt syndrome). Clinico-pathological evaluation of 9 cases].

K. Jellinger, F. Garzuly, P. Pilz, 1971, Archiv fur Psychiatrie und Nervenkrankheiten.

Infantile cerebral disorders. Clinical-neuropathological correlations to elucidate the aetiological factors.

K. Jellinger, A. Rett, H. Gross, 1968, Journal of the neurological sciences.

On the mode of action of L-deprenyl in the human central nervous system

K. Jellinger, P. Riederer, W. Birkmayer, 2005, Journal of Neural Transmission.

Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia

K. Jellinger, 2008, Neurodegenerative Diseases.

[Glioblastoma multiforme developing after a gunshot injury of the brain (author's transl)].

K. Jellinger, A. Witzmann, R. Weiss, 1981, Neurochirurgia.

Basic mechanisms of neurodegeneration: a critical update

K. Jellinger, 2010, Journal of cellular and molecular medicine.

The N-methyl-d-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissue

K. Jellinger, J. Kornhuber, P. Riederer, 1999, Acta Neuropathologica.

Neuropathobiology of non-motor symptoms in Parkinson disease

K. Jellinger, 2015, Journal of Neural Transmission.

The pathomechanisms underlying Parkinson's

K. Jellinger, 2014 .

Neurobiology of Non-Motor Symptoms in Parkinson Disease

K. Jellinger, 2014 .

The association of incident dementia with mortality in PD

K. Jellinger, 2003, Neurology.

Alzheimer Disease: The Changing View

K. Jellinger, K A Jellinger, 2001 .

Peripheral Neuropathy: A Practical Approach to Diagnosis and Management

K. Jellinger, 2001 .

Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype

K. Jellinger, I. Litvan, W. Paulus, 2001, BMC neurology.

Morbid changes in Lowe's oculo-cerebro-renal syndrome.

K. Jellinger, F. Garzuly, L. Szabó, 1973, Neuropadiatrie.

The pathomechanisms underlying Parkinson's disease

K. Jellinger, 2014, Expert review of neurotherapeutics.

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.

K. Jellinger, 2009, Biochimica et biophysica acta.

Serotonin and Sleep: Molecular, Functional and Clinical Aspects

K. Jellinger, 2009 .

Buspirone and dystonia

K. Jellinger, Karl L.R. Jansen, Karl L.R. Jansen, 1991, Neurology.

Challenges of multimorbidity of the aging brain: a critical update

K. Jellinger, J. Attems, 2015, Journal of Neural Transmission.

Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology

K. Jellinger, J. Attems, F. Lintner, 2007, Journal of the Neurological Sciences.

Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease

K. Jellinger, J. Attems, 2005, Journal of the Neurological Sciences.

Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study

K. Jellinger, J. Attems, 2004, Acta Neuropathologica.

Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.

K. Jellinger, H. Hinterhuber, G. Kemmler, 2008, Journal of psychiatric research.

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

K. Jellinger, J. Attems, 2008, Acta Neuropathologica.

Lateralisation in Parkinson disease

K. Jellinger, R. Krüger, P. Riederer, 2018, Cell and Tissue Research.

Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease

K. Jellinger, J. Attems, K. A. Jellinger, 2007, Acta Neuropathologica.

Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs

K. Jellinger, J. Attems, Magdalena Quass, 2006, Acta Neuropathologica.

The enigma of mixed dementia

K. Jellinger, 2007, Alzheimer's & Dementia.

Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease

K. Jellinger, W. Poewe, W. Poewe, 2002, Journal of Neural Transmission.

Alzheimer-type lesions in Huntington's disease

K. Jellinger, 1998, Journal of Neural Transmission.

Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors

K. Jellinger, G. Kemmler, P. Fischer, 2011, Journal of Neural Transmission.

The Neuropathologic Substrates of Vascular-Ischemic Dementia

K. Jellinger, 2005 .

Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies

K. Jellinger, 2018, Journal of Neural Transmission.

Neuropathology of Alzheimer's disease: a critical update.

K. Jellinger, C. Bancher, 1998, Journal of neural transmission. Supplementum.

Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy

K. Jellinger, J. Attems, F. Lintner, 2005, Acta Neuropathologica.

Malignant lymphomas of the nervous system

K. Jellinger, F. Seitelberger, 2004, Acta Neuropathologica.

Pelizaeus-Merzbacher disease

K. Jellinger, F. Seitelberger, 1969, Acta Neuropathologica.

Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy

K. Jellinger, J. Attems, F. Lauda, 2008, Journal of Neurology.

Pathogenesis and treatment of vascular cognitive impairment.

K. Jellinger, 2014, Neurodegenerative disease management.

Neuropathological evaluation of mixed dementia

K. Jellinger, J. Attems, K. Jellinger, 2007, Journal of the Neurological Sciences.

Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism

K. Jellinger, J. Attems, J. Attems, 2006, Acta neurologica Scandinavica.

Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study

K. Jellinger, J. Attems, 2002, Acta Neuropathologica.

Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study.

K. Jellinger, M. Haltia, T. Polvikoski, 2002, Neurology.

Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases

K. Jellinger, 2021, Journal of Neural Transmission.

Low prevalence of apolipoprotein E ε4 allele in the neurofibrillary tangle predominant form of senile dementia

K. Jellinger, M. Graeber, C. Bancher, 1997, Acta Neuropathologica.

Morphological substrates of mental dysfunction in Lewy body disease: an update.

K. Jellinger, 2000, Journal of neural transmission. Supplementum.

Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?

K. Jellinger, 2009, Acta Neuropathologica.

Con: Can neuropathology really confirm the exact diagnosis?

K. Jellinger, 2010, Alzheimer's Research & Therapy.

Pathology and pathogenesis of vascular cognitive impairment—a critical update

K. Jellinger, 2013, Front. Aging Neurosci..

Mild cognitive impairment in Parkinson disease: heterogenous mechanisms

K. Jellinger, 2012, Journal of Neural Transmission.

Chromogranin peptides in Alzheimer's disease

Christian Humpel, K. Jellinger, C. Humpel, 2004, Experimental Gerontology.

Niedermeyer's Electroencephalography: Basic Principles, Clinical Applications, and Related Fields, 6th edn

K. Jellinger, K. A. Jellinger, 2011 .

Cardiovascular diseases and hippocampal infarcts

K. Jellinger, A. Paetau, I. Alafuzoff, 2011, Hippocampus.

Is Braak staging valid for all types of Parkinson’s disease?

K. Jellinger, 2018, Journal of neural transmission.

Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

K. Jellinger, T. Hortobágyi, J. Trojanowski, 2021, Acta Neuropathologica.

K. Jellinger, 2004, Journal of Neural Transmission.

Hippocampal sclerosis: a common pathological feature of dementia in very old humans

K. Jellinger, 2004, Acta Neuropathologica.

To the editor

K. Jellinger, 2006, Brain Tumor Pathology.

Prevalence and Pathology of Dementia with Lewy Bodies in the Oldest Old: A Comparison with Other Dementing Disorders

K. Jellinger, J. Attems, 2011, Dementia and Geriatric Cognitive Disorders.

Traumatic basal ganglia hemorrhage

K. Jellinger, 1990, Neurology.

Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage

K. Jellinger, J. Attems, F. Lauda, 2007, European journal of neurology.

Senile Dementia with Tangles (Tangle Predominant Form of Senile Dementia)

K. Jellinger, C. Bancher, 1998, Brain pathology.

An autopsy case of intravascular malignant lymphoma presenting with intracranial B-cell type malignant lymphoma.

K. Jellinger, 1997, Brain tumor pathology.

Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology

K. Jellinger, J. Attems, F. Lintner, 2004, Acta Neuropathologica.

Pathomechanisms of Vascular Depression in Older Adults

K. Jellinger, 2020, International journal of molecular sciences.

Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study

K. Jellinger, 2003, Acta Neuropathologica.

Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia

K. Jellinger, H. Lassmann, F. Leblhuber, 2005, European Archives of Psychiatry and Clinical Neuroscience.

The neuropathological diagnosis of Alzheimer disease.

K. Jellinger, K A Jellinger, 1998, Journal of neural transmission. Supplementum.

Proposals for Re-evaluation of Current Autopsy Criteria for the Diagnosis of Alzheimer’s Disease

K. Jellinger, C. Bancher, K. Jellinger, 1997, Neurobiology of Aging.

Classification of dementias based on functional morphology

K. Jellinger, C. Bancher, 1994 .

Principles of frontal lobe function

K. Jellinger, 2003 .

Understanding the pathology of vascular cognitive impairment

K. Jellinger, Kurt A. Jellinger, 2005, Journal of the Neurological Sciences.

Atypical Parkinsonian Disorders – Clinical and Research Aspects

K. Jellinger, 2005 .

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

K. Jellinger, K. Lange, P. Riederer, 1992, Neuroscience Letters.

TAR-DNA binding protein-43 and alterations in the hippocampus

K. Jellinger, A. Paetau, I. Alafuzoff, 2011, Journal of Neural Transmission.

Hypertrophy of the inferior olives

K. Jellinger, K Jellinger, K. Jellinger, 1973, Zeitschrift für Neurologie.

Birth injury of the spinal cord. Report of two necropsy cases with several weeks survival.

K. Jellinger, A. Schwingshackl, 1973, Neuropadiatrie.

Neuropathology of Nonmotor Symptoms of Parkinson's Disease.

K. Jellinger, 2017, International review of neurobiology.

Mild Cognitive Impairment. Aging to Alzheimer's disease

K. Jellinger, K. A. Jellinger, 2003 .

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease

K. Jellinger, C. Jack, T. Montine, 2015, Acta Neuropathologica.

Brain Neurotransmitter Amines in Cerebral Ischemia and Stroke

K. Jellinger, P. Riederer, 1981 .

Correlations between cortical and subcortical tau pathology

K. Jellinger, J. Attems, A. Thomas, 2012, Neuropathology and applied neurobiology.

Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice

K. Jellinger, J. Attems, R. Nitsch, 2011, Journal of Neural Transmission.

Calcium‐binding protein secretagogin‐expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease

K. Jellinger, J. Attems, M. Preusser, 2007, Neuropathology and applied neurobiology.

The Handbook of Neuroprotection

K. Jellinger, K. A. Jellinger, 2011 .

Traumatic vascular disease of the spinal cord. In Handbook of clinical neurology

K. Jellinger, 1972 .

Late Death in Cases of Internal Hydrocephalus Treated during Early Childhood

K. Jellinger, S. Salah, M. Sunder-Plassmann, 1975 .

Trauma as an etiologic agent in Parkinson disease.

K. Jellinger, 1989, Movement disorders : official journal of the Movement Disorder Society.

Dopamine D2 receptor density remains constant in treated Parkinson's disease

Philip Seeman, Mark Guttman, Peter Riederer, 1986, Annals of neurology.

Brain monoamines in metabolic coma and stroke.

K. Jellinger, P. Riederer, 1978, Advances in neurology.

Changes of some putative neurotransmitters in human cerebral infarction.

K. Jellinger, P. Riederer, P. Kothbauer, 1978, Journal of neural transmission. Supplementum.

Brain monoamines in human hepatic encephalopathy

K. Jellinger, P. Riederer, S. Wuketich, 1978, Acta Neuropathologica.

Brain monoamines in metabolic (endotoxic) coma a preliminary biochemical study in human postmortem material

K. Jellinger, P. Riederer, 2005, Journal of Neural Transmission.

Central Aminergic Function and its Disturbance by Hepatic Disease: The Current Status of L-valine Pharmacotherapy in Metabolic Coma

K. Jellinger, P. Riederer, E. Kienzl, 1981 .

Multiple system atrophy with hippocampal pathology

K. Jellinger, 2022, Brain pathology.

The Bereitschaftspotential: Movement Related Cortical Potentials

K. Jellinger, K. A. Jellinger, 2003 .

Overview of morphological changes in Parkinson's disease.

K. Jellinger, K Jellinger, 1987, Advances in neurology.

Positron emission tomography in vascular dementia.

K. Jellinger, 1998, Journal of the neurological sciences.

Cognitive Impairment and the Diabetic Brain

K. Jellinger, 2015 .

Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients.

K. Jellinger, J. Attems, P. Bugert, 2012, Journal of proteomics.

Imaging neuroscience – Clinical frontiers for diagnosis and management

K. Jellinger, 2003 .

[Necrotizing myopathy with antilipemic agents. Case report and review of the literature].

K. Jellinger, W. Grisold, U. Zifko, 1993, Der Nervenarzt.

Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect

K. Jellinger, H. Reichmann, P. Riederer, 1990, Journal of neurochemistry.

Pathomechanisms of cognitive impairment in progressive supranuclear palsy

K. Jellinger, 2023, Journal of Neural Transmission.

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies

K. Jellinger, 2004, Neurology.

Susceptibility of Brains from Patients with Alzheimer's Disease to Oxygen-Stimulated Lipid Peroxidation and Differential Scanning Calorimetry

K. Jellinger, S. Heckers, L. Frölich, 1992 .

The Paroxysmal Disorders

K. Jellinger, 2011 .

Parkinson’s Disease. Methods and Protocols

K. Jellinger, 2001 .

Practical Guide for Clinical Neurophysiologic Testing: EEG

K. Jellinger, K. A. Jellinger, 2009 .

Neuropathological findings in multiple system atrophy with cognitive impairment

K. Jellinger, 2020, Journal of Neural Transmission.

Very old onset parkinsonism: A clinical-pathological study.

K. Jellinger, 2018, Parkinsonism & related disorders.

Different patterns of hippocampal tau pathology in Alzheimer’s disease and PART

K. Jellinger, 2018, Acta Neuropathologica.

Cerebral Multimorbidity in Aging

K. Jellinger, 2016 .

Commentary on the Paper "PART, a Distinct Tauopathy, Different from Classical Sporadic Alzheimer Disease"

K. Jellinger, 2016 .

Neuropathological subtypes of Alzheimer’s disease

K. Jellinger, Kurt A. Jellinger, 2011, Acta Neuropathologica.

Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects

K. Jellinger, C. Bancher, 2004, Acta Neuropathologica.

Neuropathologic diagnosis of Alzheimer disease: consensus between practicing neuropathologists?

K. Jellinger, C. Bancher, W. Paulus, 1997, Alzheimer disease and associated disorders.

Agyria-Pachygyria (Lissencephaly Syndrome)

K. Jellinger, A. Rett, 1976, Neuropadiatrie.

Neurology for the Non‐Neurologist

K. Jellinger, 2005 .

A conventional approach to dorsal raphe nucleus staining

K. Jellinger, 2000, Neuropathology and Applied Neurobiology.

[Frontal lobe dementia. Clinical-pathologic case reports].

K. Jellinger, F. Leblhuber, C. Bancher, 1999, Fortschritte der Neurologie-Psychiatrie.

Chronic encephalitis in X-linked agammaglobulinaemia.

K. Jellinger, M. Eibl, W. Grisold, 1981, Acta neuropathologica. Supplementum.

Distribution of amyloid plaques in the cerebellum in Alzheimer's disease

K. Jellinger, 2004, Acta Neuropathologica.

Diagnostic accuracy of Alzheimer’s disease: A clinicopathological study

K. Jellinger, 2009, Acta Neuropathologica.

Molecular Aspects of Neurotransmitter-Receptor Changes in Hepatic Encephalopathy

K. Jellinger, P. Riederer, E. Kienzl, 1984 .

Clinicopathological analysis of dementia disorders in the elderly

K. Jellinger, P. Fischer, W. Danielczyk, 1990, Journal of the Neurological Sciences.

Human brain phenolsulfotransferase. Regional distribution in Parkinson's disease

K. Jellinger, H. Baran, 1992, Journal of neural transmission. Parkinson's disease and dementia section.

Type VIII collagen in the normal and diseased human brain.

K. Jellinger, E. Sage, W. Paulus, 1992, Acta histochemica. Supplementband.

Microglial reaction in Pick's disease

K. Jellinger, C. Bancher, W. Paulus, 1993, Neuroscience Letters.

Reviewers List

Carol Keefer, Liz Glass, Basil J. Nikolau, 2004, Transgenic Research.

Morphometry of the corpus callosum in normal aging and Alzheimer's disease.

K. Jellinger, E. Wenger, S. Weis, 1991, Journal of neural transmission. Supplementum.

Corticobasal Degeneration and Related Disorders

K. Jellinger, 2001 .

The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder

K. Jellinger, 2023, Journal of Neural Transmission.

Urinary dopamine sulfate conjugates in Parkinson’s disease

K. Jellinger, P. Riederer, W. Danielczyk, 1990 .

Urinary dopamine sulfate: regulations and significance in neurological disorders.

K. Jellinger, P. Riederer, G. Laux, 1990, Journal of neural transmission. Supplementum.

Prevalence of Alzheimer lesions in Parkinson's disease

K. Jellinger, 2003, Movement disorders : official journal of the Movement Disorder Society.

Wayfinding Behavior, Cognitive Mapping and Other Spatial Processes Reginald G. Golledge, ed. The Johns Hopkins University Press, Baltimore & London, 1999. 428 pp., ISBN 0–8010–5993–X.

K. Jellinger, K. A. Jellinger, 2000 .

Different Tau Pathology Pattern in Two Clinical Phenotypes of Progressive Supranuclear Palsy

K. Jellinger, 2008, Neurodegenerative Diseases.

Recent developments in the pathology of Parkinson's disease.

K. Jellinger, K A Jellinger, 2002, Journal of neural transmission. Supplementum.

Different patterns of hippocampal subfield pathology in Lewy body disease and Alzheimer's disease

K. Jellinger, 2021, Neuropathology and applied neurobiology.

Amyloid and tau: neither chicken nor egg but two partners in crime!

K. Jellinger, J. Attems, 2013, Acta Neuropathologica.

α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study

K. Jellinger, Kurt A. Jellinger, 2003, Acta Neuropathologica.

Potential role of α‐synuclein in neurodegeneration: studies in a rat animal model

K. Jellinger, 2012, Journal of neurochemistry.

Forensic Neuropsychology: Fundamentals and Practice

K. Jellinger, 1999 .

Textbook of Epilepsy Surgery

K. Jellinger, Kurt A. Jellinger, 2009 .

The child with traumatic brain injury or cerebral palsy – A context‐sensitive, family‐based approach to development

K. Jellinger, 2007 .

Postmortem Examination of Vascular Lesions in Cognitive Impairment: A Survey Among Neuropathological Services

K. Jellinger, L. Pantoni, I. Alafuzoff, 2006, Stroke.

Statistical investigations of the age dependence of neuroaxonal dystrophy.

K. Jellinger, G. Haub, 1968, German medical monthly.

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

K. Jellinger, J. Attems, Kurt A. Jellinger, 2006, Acta Neuropathologica.

Interaction between α-synuclein and tau in Parkinson's disease Comment on Wills et al.: Elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210–218

K. Jellinger, 2011, Experimental Neurology.

Synuclein deposition and non-motor symptoms in Parkinson disease

K. Jellinger, 2011, Journal of the Neurological Sciences.

Brain iron and ferritin in Parkinson's and Alzheimer's diseases

K. Jellinger, P. Riederer, I. Grundke‐Iqbal, 1990, Journal of neural transmission. Parkinson's disease and dementia section.

The Banana Lady and other stories of curious behaviour and speech

K. Jellinger, 2007 .

Multiple Sclerosis. Psychosocial and Vocational Interventions

K. Jellinger, 2004 .

Epilepsy in our World: Stories of Living with Seizures from Around the World

K. Jellinger, 2009 .

Formation and development of Lewy pathology: a critical update

K. Jellinger, Kurt A. Jellinger, 2009, Journal of Neurology.

Clinicopathological analysis of dementia disorders in the elderly--an update.

K. Jellinger, 2006, Journal of Alzheimer's disease : JAD.

Meningococcal Disease: Methods and Protocols

K. Jellinger, K. A. Jellinger, 2002 .

Absence of α-synuclein pathology in postencephalitic parkinsonism

K. Jellinger, 2009, Acta Neuropathologica.

Is Multiple System Atrophy a Prion-like Disorder?

K. Jellinger, G. Wenning, N. Stefanova, 2021, International journal of molecular sciences.

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies

Sonja W. Scholz, K. Jellinger, W. Poewe, 2014, Parkinsonism & related disorders.

Etiology, Pathology, and Pathogenesis

K. Jellinger, G. Wenning, N. Stefanova, 2010 .

19. Postencephalitic Parkinsonism

K. Jellinger, K. A. Jellinger, 2011 .

Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration?

K. Jellinger, S. Ropele, R. Schmidt, 2011, Acta Neuropathologica.

European Handbook of Neurological Management

K. Jellinger, Kurt A. Jellinger, 2007 .

Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.

K. Jellinger, I. Wichart, N. Rösler, 1996, Journal of neurology, neurosurgery, and psychiatry.

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease.

K. Jellinger, I. Wichart, N. Rösler, 1996, Journal of neurology, neurosurgery, and psychiatry.

Clinical and neuropathological correlates of Lewy body disease

K. Jellinger, K. Seppi, G. Wenning, 2003, Acta Neuropathologica.

The need to unify neuropathological assessments of vascular alterations in the ageing brain Multicentre survey by the BrainNet Europe consortium

K. Jellinger, T. Hortobágyi, J. Attems, 2012, Experimental Gerontology.

Law and the Brain

K. Jellinger, 2007 .

Letter to the editor

K. Jellinger, 2005, Acta Neurochirurgica.

Changing concepts in Parkinson's disease Glenda Halliday Roger

K. Jellinger, 2011, The Lancet Neurology.

Clinico-pathological correlations in Parkinson's disease

Werner Paulus, K. Jellinger, W. Paulus, 1992, Clinical Neurology and Neurosurgery.

Neurobiology of cognitive impairment in Parkinson’s disease

K. Jellinger, 2012, Expert review of neurotherapeutics.

Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?

K. Jellinger, W. Linert, E. Kienzl, 1999, Life sciences.

Cerebral amyloid angiopathy in Lewy body disease

K. Jellinger, J. Attems, K. Jellinger, 2008, Journal of Neural Transmission.

Pathomechanisms of depression in progressive supranuclear palsy

K. Jellinger, 2023, Journal of Neural Transmission.

The morphological basis of mental dysfunction in Parkinson's disease

K. Jellinger, 2006, Journal of the Neurological Sciences.

The basis for behavioural disturbances in dementia.

K. Jellinger, 1997, Journal of neurology, neurosurgery, and psychiatry.

Traumatic brain injury as a risk factor for Alzheimer disease

K. Jellinger, I. Litvan, W. Paulus, 2001 .

Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study.

K. Jellinger, Kurt A Jellinger, 2002, Neurology.

Branched Chain Amino Acids in Hepatic Failure: Effects on Brain Function

K. Jellinger, P. Riederer, E. Kienzl, 1983 .

Multiple system atrophy: pathogenic mechanisms and biomarkers

K. Jellinger, G. Wenning, 2016, Journal of Neural Transmission.

Recent advances in multiple system atrophy

K. Jellinger, 2016 .

Pathogenesis of Multiple System Atrophy - Recent Developments

K. Jellinger, Kurt A. Jellinger, 2015 .

Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy)

K. Jellinger, W. Poewe, G. Wenning, 2003, Acta Neuropathologica.

Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis.

K. Jellinger, J. Kornhuber, K. Lange, 1991, Journal of neural transmission. Supplementum.

Heterogenous mechanisms of mild cognitive impairment in Parkinson’s disease

K. Jellinger, 2012, Journal of Neural Transmission.

Significance of brain lesions in Parkinson disease dementia and Lewy body dementia.

K. Jellinger, 2009, Frontiers of neurology and neuroscience.

CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.

K. Jellinger, P. Riederer, W. Birkmayer, 1978, Journal of neural transmission. Supplementum.

Aphasia and its Therapy

K. Jellinger, K. A. Jellinger, 2003 .

Peripheral nerve involvement in the Rett syndrome

K. Jellinger, W. Grisold, D. Armstrong, 1990, Brain and Development.

Syndrome of continuous muscle fiber activity and plasmacytoma with IgM paraproteinemia

K. Jellinger, W. Grisold, U. Zifko, 1994, Neurology.

Effectiveness of Rehabilitation for Cognitive Deficits

K. Jellinger, 2006 .

Psychogenic Movement Disorders: Neurology and Psychiatry

K. Jellinger, 2006 .

Lewy body/α-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study

K. Jellinger, 2009, Acta Neuropathologica.

A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.

K. Jellinger, 2009, Biochimica et biophysica acta.

Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics

K. Jellinger, H. Mucke, M. Haushofer, 2001, Journal of Neural Transmission.

Dopamine transporter imaging in autopsy‐confirmed Parkinson's disease and multiple system atrophy

Susanne Pirker, Kurt Jellinger, Martha Hoffmann, 2012, Movement disorders : official journal of the Movement Disorder Society.

Neuropathology in Parkinson’s disease with mild cognitive impairment

K. Jellinger, 2010, Acta Neuropathologica.

Sleep and Brain Plasticity

K. Jellinger, K. A. Jellinger, 2003 .

Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia.

K. Jellinger, P. Seeman, W. Tourtellotte, 1990, European neurology.

Parkinsonism and persistent vegetative state after head injury.

K. Jellinger, 2004, Journal of neurology, neurosurgery, and psychiatry.

DeJong's The Neurologic Examination, 6th edn

K. Jellinger, K. A. Jellinger, 2006 .

Cerebral Blood Flow and Metabolism, 2nd edition

K. Jellinger, K. A. Jellinger, 2002 .

Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.

K. Jellinger, G. Kemmler, P. Fischer, 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia

K. Jellinger, 2023, Journal of Neural Transmission.

Is Alzheimer's disease a vascular disorder?

K. Jellinger, 2003, Journal of Alzheimer's disease : JAD.

Neuropathological Distinctions and Similarities in Movement Disorders with Dementia

K. Jellinger, 2003 .

Memory deficits in advanced Parkinson's disease

K. Jellinger, P. Fischer, G. Gatterer, 1990, Journal of neural transmission. Parkinson's disease and dementia section.

Traumatic brain injury and Alzheimer's disease neuropathology

K. Jellinger, 2019, Alzheimer's & Dementia.

Multiple Sclerosis: Recovery of Function and Neurorehabilitation

K. Jellinger, 2011 .

Morphological differences between dementia with Lewy bodies and Parkinson's disease‐dementia

K. Jellinger, 2021, Neuropathology and applied neurobiology.

Striatal dopamine transporter activity may predict β-amyloid pathology in dementia with Lewy bodies

K. Jellinger, 2020, Neurology.

Challenges in neuronal apoptosis.

K. Jellinger, 2006, Current Alzheimer research.

Vascular parkinsonism

K. Jellinger, 2005, Journal of Neurology.

Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter

K. Jellinger, J. Attems, M. Esiri, 2013, Neuropathology and applied neurobiology.

Parkinson's Disease. Diagnosis and Management

K. Jellinger, 2002 .

Critical evaluation of the Braak staging scheme for Parkinson's disease

K. Jellinger, Kurt A. Jellinger, 2010, Annals of neurology.

Alzheimer Pathology in the olfactory bulb

K. Jellinger, J. Attems, 2005, Neuropathology and applied neurobiology.

Immunoreactivities of amyloid beta peptide((1-42)) and total tau protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus.

K. Jellinger, C. Bancher, C. Wallesch, 2004, Journal of neural transmission.

Mild cognitive impairment in Parkinson’s disease: a critical update

K. Jellinger, 2011 .

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

K. Jellinger, G. Reynolds, J. Kornhuber, 2005, Journal of Neural Transmission.

Neuropathologic changes in Parkinson disease with late onset of dementia.

K. Jellinger, K. Seppi, G. Wenning, 2003, Archives of neurology.

Pelizacus-Merzbacher disease. Transitional form between classical and co-natal (Seitelberger) type.

K. Jellinger, F. Seitelberger, 1969, Acta neuropathologica.

CSF biomarkers in different phenotypes of Parkinson disease

K. Jellinger, 2012, Journal of Neural Transmission.

Mortality in Parkinson's disease

K. Jellinger, 2005, Acta neurologica Scandinavica.

Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs.

K. Jellinger, J. Attems, Magdalena Quass, 2007, Acta neuropathologica.

IN DEMENTIA WITH LEWY BODIES, BRAAK STAGE DETERMINES PHENOTYPE, NOT LEWY BODY DISTRIBUTION

K. Jellinger, 2008, Neurology.

CORRECTION

K. Jellinger, 2008, Neurology.

The Headaches, 3rd edn

K. Jellinger, K. A. Jellinger, 2009 .

Neuropathology of dementia in Parkinson's disease

K. Jellinger, 2006, Annals of neurology.

Age-associated prevalence and risk factors of Lewy body pathology in a general population

K. Jellinger, 2003, Acta Neuropathologica.

Prevalence of vascular lesions in Dementia with Lewy Bodies. A postmortem study

K. Jellinger, 2003, Journal of Neural Transmission.

Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.

K. Jellinger, 2006, Parkinsonism & related disorders.

Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin‐6 in Alzheimer's disease patients

K. Jellinger, I. Wichart, N. Rösler, 2001, Acta neurologica Scandinavica.

Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies

K. Jellinger, J. Attems, 2009 .

Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA).

K. Jellinger, 2005, Journal of neuropathology and experimental neurology.

Quantitative neuropathologic analysis of Pick's disease cases

K. Jellinger, 2004, Acta Neuropathologica.

Alzheimer's changes in non-demented and demented patients

K. Jellinger, 2004, Acta Neuropathologica.

Dementia with Lewy Bodies: Dementia with Lewy bodies: relationships to Parkinson's and Alzheimer's diseases

K. Jellinger, C. Bancher, 1996 .

Pathobiochemical Aspects of Parkinson’s Disease and Dementia of Alzheimer Type

K. Jellinger, S. Heckers, H. Reichmann, 1990 .

Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia?

K. Jellinger, C. Bancher, I. Wichart, 1996, Journal of neural transmission. Supplementum.

Neuropathology and general autopsy findings in nondemented aged subjects.

K. Jellinger, J. Attems, 2012, Clinical neuropathology.

The impact of cerebrovascular lesions in Alzheimer disease

K. Jellinger, Erich PhD Mitter-Ferstl, 2003, Journal of Neurology.

Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia

K. Jellinger, 2000, Journal of neurology, neurosurgery, and psychiatry.

Mild cognitive impairment in dementia with Lewy bodies: an update and outlook.

K. Jellinger, 2023, Journal of neural transmission.

The cholinergic basal forebrain in Lewy body dementia and Alzheimer’s disease

K. Jellinger, 2015, Journal of Neurology.

Disturbance of the nigro–amygdaloid connections in dementia with Lewy bodies

K. Jellinger, 2002, Journal of the Neurological Sciences.

Neuropathology and pathophysiology of multiple system atrophy

K. Jellinger, 2012, Neuropathology and applied neurobiology.

Understanding G protein‐coupled receptors and their role in the CNS (Molecular and Cellular Neurobiology)

K. Jellinger, 2003 .

Adult Neurogenesis: Stem cells and neuronal development in the adult brain

K. Jellinger, 2007 .

Structural basis of dementia in neurodegenerative disorders.

K. Jellinger, 1996, Journal of neural transmission. Supplementum.

[Progressive pallidal atrophy].

K. Jellinger, 1968, Journal of the neurological sciences.

Blunt Traumatic Brain Injury and Alzheimer Pathology

K. Jellinger, 2022, Dementia and Geriatric Cognitive Disorders.

The prevalence of Creutzfeldt-Jakob disease.

K. Jellinger, H. Budka, 1996, Neurodegeneration.

New developments in the pathology of Parkinson's disease.

K. Jellinger, K Jellinger, 1990, Advances in neurology.

Brain quinolinic acid in Alzheimer's dementia

K. Jellinger, P. Riederer, J. Halket, 1989 .

Neuropathological findings in multiple system atrophy with dystonia

K. Jellinger, 2002, Journal of neurology, neurosurgery, and psychiatry.

Iron in the Parkinsonian substantia nigra.

P Riederer, K. Jellinger, E. Hirsch, 1997, Movement disorders : official journal of the Movement Disorder Society.

Drug Therapy for Stroke Prevention

K. Jellinger, 2002 .

Unusual presentation of a primary spinal lymphoma

K. Jellinger, W. Grisold, 2002, Journal of neurology, neurosurgery, and psychiatry.

Current Topics in Extrapyramidal Disorders

K. Jellinger, P. Riederer, A. Carlsson, 1980, Journal of Neural Transmission.

The Motoneurone and its Muscle Fibres

K. Jellinger, 2007 .

Neurodegenerative Disorders. A Clinical Guide

K. Jellinger, 2012 .

Kynurenines in the Brain, from Experiments to Clinics

K. Jellinger, 2006 .

Animal Models of Acute Neurological Injuries

K. Jellinger, 2009 .

Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer’s disease

K. Jellinger, C. Humpel, J. Marksteiner, 2000, Acta Neuropathologica.

Neuroglia, 2nd edn

K. Jellinger, 2011 .

Myotonic Dystrophy: Present Management, Future Therapy

K. Jellinger, 2004 .

The Human Nervous System Structure and Function, 6th edn

K. Jellinger, K. A. Jellinger, 2009 .

Allocortical neurofibrillary changes in progressive supranuclear palsy

K. Jellinger, H. Braak, E. Braak, 2004, Acta Neuropathologica.

Thepedunculopontine nucleus inParkinson's disease, progressive supranuclear palsy andAlzheimer's disease

K. Jellinger, 1988 .

Parkinson disease with old-age onset.

K. Jellinger, Kurt A Jellinger, 2003, Archives of neurology.

Antineuronal antibodies in small cell lung carcinoma —a singificance for paraneoplastic syndromes?

K. Jellinger, W. Popp, W. Grisold, 2004, Acta Neuropathologica.

Depression in dementia with Lewy bodies: a critical update

K. Jellinger, 2023, Journal of Neural Transmission.

Transient Ischemic Attack and Stroke – Diagnosis, Investigation and Management

K. Jellinger, 2009 .

What are the Main Pathogenetic Features of Vascular Cognitive Impairment

K. Jellinger, 2017 .

European Journal of Geriatrics

K. Jellinger, J. Attems, F. Lintner, 2006 .

Neuropathological Aspects of Hypsarrhythmia

K. Jellinger, 1970, Neuropadiatrie.

Aids to the Examination of the Peripheral Nervous System

K. Jellinger, 2001 .

Neural Stem Cells. Methods and Protocols

K. Jellinger, 2004 .

Zen and the Brain Towards an Understanding of Meditation and Consciousness

K. Jellinger, K A Jellinger, 2001 .

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

I Litvan, K. Jellinger, K. Chaudhuri, 1996, Journal of neurology, neurosurgery, and psychiatry.

Marchiafava-Bignami-Syndrom

K. Jellinger, 1961, Acta Neuropathologica.

Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

I Litvan, Y Agid, J J Bartko, 1996, Neurology.

Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease

K. Jellinger, H. Wiśniewski, H. Budka, 1989, Brain Research.

Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.

K. Jellinger, J. Jankovic, Y. Agid, 1998, Archives of neurology.

Lehrbuch der Schmerztherapie/Textbook of Pain Therapy

K. Jellinger, 2001 .

Gene Therapy for Neurological Disorders and Brain Tumors

K. Jellinger, X. Breakefield, E. Chiocca, 1997, Nature Medicine.

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

I Litvan, G K Wenning, W Poewe, 1998, Journal of neurology, neurosurgery, and psychiatry.

Accuracy of the Clinical Diagnosis of Corticobasal Degeneration

J. P. Brandel, K. Jellinger, J. Jankovic, 1997, Neurology.

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.

I Litvan, K. Jellinger, K. Chaudhuri, 1997, Brain : a journal of neurology.

Practical Neurology, 3rd edn

K. Jellinger, 2009 .

A Physicochemical Approach to Characterize [3H] -Tryptamine-Binding-Sites in Human Brain

K. Jellinger, P. Riederer, E. Kienzl, 1985 .

Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study

I Litvan, G K Wenning, W Poewe, 2000, Neurology.

Histological subtypes and prognostic problems in meningiomas

K. Jellinger, F. Slowik, K. Jellinger, 2004, Journal of Neurology.

Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

I Litvan, K. Jellinger, P. Lantos, 1994, Neurology.

What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study

K. Ray Chaudhuri, J. P. Brandel, K. Jellinger, 1997, Neurology.

Increased serum neopterin concentrations in a patient with Creutzfeldt-Jakob disease.

K. Jellinger, D. Fuchs, F. Leblhuber, 1996, Journal of neurology, neurosurgery, and psychiatry.

Neuroimaging of Normal Aging and Uncommon Causes of Dementia edited by Franz Fazekas, Reinhold Schmidt and A. Alavi. ICG Publ., Dordtrecht, the Netherlands, 1998. 244 pp.

K. Jellinger, 2000 .

Update on Alzheimer’s Disease

K. Jellinger, 2015, EMJ Neurology.

Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration

K. Jellinger, J. Jankovic, A. Lang, 1999, Journal of Neurology.

Functional magnetic resonance imaging: an introduction to methods

K. Jellinger, K. A. Jellinger, 2003 .

Circulation disorders of the spinal cord

K. Jellinger, 1972, Acta Neurochirurgica.

The Neurobiology of Australian Marsupials: Brain Evolution in the Other Mammalian Radiation

K. Jellinger, 2011 .

Neuropathological substrates of Alzheimer's disease and Parkinson's disease.

K. Jellinger, 1987, Journal of neural transmission. Supplementum.

Reprogramming the Cerebral Cortex: Plasticity Following Central and Peripheral Lesions

K. Jellinger, K. A. Jellinger, 2007 .

Synaptic pathology in alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles

K. Jellinger, H. Lassmann, F. Seitelberger, 1992, Neuroscience.

The Visual Brain in Action

K. Jellinger, 2007 .

6 – Alzheimer's Disease

K. Jellinger, 2007 .

Scintigraphy in lymphomas and leukemia of the brain

K. Jellinger, W. Heiss, I. Podreka, 2004, Neuroradiology.

Vascular Cognitive Impairment in Clinical Practice

K. Jellinger, 2009 .

The neuropathologic diagnosis of secondary parkinsonian syndromes.

K. Jellinger, 1996, Advances in neurology.

Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders

I Litvan, J J Bartko, K. Jellinger, 1996, Journal of neuropathology and experimental neurology.

Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer’s disease

K. Jellinger, I. Litvan, W. Paulus, 2001, European journal of neurology.

Determination of Plaque and Tangle Density in Demyelinated versus Nondemyelinated Cortical Areas in Multiple Sclerosis

K. Jellinger, H. Lassmann, M. Bradl, 2008 .

Multimodality therapy of supratentorial high-grade gliomas

K. Jellinger, G. Alth, W. Grisold, 1986 .

Plasma levels of amyloid ß-protein 42 are increased in women with mild cognitive impairment

K. Jellinger, P. Fischer, I. Blasko, 2018 .

TAU AND UBIQUITIN IMMUNOREACTIVITY AT DIFFERENT STAGES OF FORMATION OF ALZHEIMER NEUROFIBRILLARY TANGLES

K. Jellinger, H. Wiśniewski, H. Budka, 1989, Progress in clinical and biological research.

Morphology and Aetiology

K. Jellinger, J. Suzuki, S. Nyström, 1979 .

[Sex differences in Alzheimer's disease].

K. Jellinger, H. Schmidt, G. Ladurner, 2008, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater.

Iron and ferritin in substantia nigra in Parkinson's disease.

K. Jellinger, P. Riederer, M. Youdim, 1993, Advances in neurology.

Letters to the Editor Related to New Topics

K. Jellinger, F. Walker, Mckhann, 2022 .

[Infantile neuroaxonal dystrophy. Early form with preferential cerebellar involvement].

K. Jellinger, F. Seitelberger, W. Rosenkranz, 1968, Acta neuropathologica.

What is new in degenerative dementia disorders?

K. Jellinger, 1999, Wiener klinische Wochenschrift.

Ageing and Dementia

K. Jellinger, F. Fazekas, M. Windisch, 1998, Journal of Neural Transmission. Supplementa.

Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activity.

K. Jellinger, P. Riederer, 1984, Advances in neurology.

The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.

K. Jellinger, M. Graeber, C. Bancher, 1996, Biochemical and biophysical research communications.

Understanding Conflicting Neuropathological Findings.

K. Jellinger, 2016, JAMA neurology.

Interrater reliability in the neuropathologic diagnosis of Alzheimer's disease

K. Jellinger, W. Paulus, C. Bancher, 1992, Neurology.

Interlaboratory comparison of neuropathology assessment in Alzheimer's disease.

K. Jellinger, P. Fischer, C. Bancher, 1995, Journal of neuropathology and experimental neurology.

Commentary on “Comparison of clinical and neuropathologic diagnoses of Alzheimer’s disease in 3 epidemiologic samples”

K. Jellinger, 2006, Alzheimer's & Dementia.

Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer's disease patients

K. Jellinger, I. Wichart, N. Rösler, 2001, Neuroscience Letters.

Clinical validity of Braak staging in the oldest-old

K. Jellinger, 2000, Acta Neuropathologica.

Apoptosis Techniques and Protocols, 2nd Edition

K. Jellinger, 2002 .

Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement

K. Jellinger, D. Jeste, P. Scheltens, 2014, Alzheimer disease and associated disorders.

K. Jellinger, 2004, Journal of Neural Transmission.

Brain Imaging in Substance Abuse: Research, Clinical, and Forensic Applications

K. Jellinger, 2002 .

Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons

K. Jellinger, J. Attems, S. Steurer, 2007, Experimental Gerontology.

Neurobiology of cognitive impairment in Parkinson’s disease

K. Jellinger, 2012, Expert review of neurotherapeutics.

Neuropathology of Nonmotor Symptoms of Parkinson's Disease.

K. Jellinger, 2017, International review of neurobiology.

Synuclein deposition and non-motor symptoms in Parkinson disease

K. Jellinger, 2011, Journal of the Neurological Sciences.

The diabetic brain and cognition

K. Jellinger, M. Kamal, M. Chopp, 2017, Journal of Neural Transmission.

K. Jellinger, T. Hortobágyi, T. Montine, 2015, Acta Neuropathologica.

Striatal beta-amyloid deposition in Parkinson disease with dementia.

K. Jellinger, 2008, Journal of neuropathology and experimental neurology.

Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases.

K. Jellinger, G. Reynolds, P. Riederer, 2006, Journal of neural transmission. Supplementum.

Cellular action of MAO inhibitors.

K. Jellinger, P. Riederer, C. Konradi, 1987, Journal of neural transmission. Supplementum.

Ions in the Brain: Normal Function, Seizures, and Stroke

K. Jellinger, K. A. Jellinger, 2004 .

Hypertrophy of the inferior olives. Report on 29 cases.

K. Jellinger, 1973, Zeitschrift fur Neurologie.

Oxford Handbook of Transcranial Stimulation

K. Jellinger, 2009 .

Movement disorders with tau protein cytoskeletal pathology.

K. Jellinger, 1999, Advances in neurology.

Parkinsonism due to binswanger's subcortical arteriosclerotic encephalopathy

K. Jellinger, 1996, Movement disorders : official journal of the Movement Disorder Society.

Handbook of Clinical Neurology

K. Jellinger, 2009 .

Infantile neuroaxonale Dystrophie

K. Jellinger, F. Seitelberger, W. Rosenkranz, 1968, Acta Neuropathologica.

Is there pure vascular dementia in old age?

K. Jellinger, J. Attems, 2010, Journal of the Neurological Sciences.

The implications of increased iron in parkinsonian substantia nigra and its high affinity binding to melanin for dopamine neuron degeneration

K. Jellinger, H. Reichmann, P. Riederer, 1990 .

Excessive hypernatremia and hyperosmolality associated with germinoma in the hypothalamic and pituitary region.

K. Jellinger, W. Waldhäusl, J. Zazgornik, 1974, European neurology.

The Neurology of AIDS, 2nd edn

K. Jellinger, 2005 .

Parkinson's disease putamen: Normal concentration of synaptic membrane marker antigens

K. Jellinger, P. Riederer, O. Jørgensen, 2005, Journal of Neural Transmission.

14C-Tryptamine Binding in Parkinson’s Disease and Hepatic Coma

K. Jellinger, P. Riederer, E. Kienzl, 1984 .

Pharmacological therapy in progressive supranuclear palsy.

K. Jellinger, C. Goetz, I. Litvan, 1998, Archives of neurology.

Lateralisation in Parkinson disease

K. Jellinger, R. Krüger, P. Riederer, 2018, Cell and Tissue Research.

Uncommon Causes of Movement Disorders: Pallidal and thalamic atrophies

K. Jellinger, 2011 .

Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism

K. Jellinger, I. Litvan, G. Wenning, 2005, Journal of Neural Transmission.

Nuclear and Fascicular Oculomotor Nerve Lesions in Brain-Stem Infarcts: A Clinicomorphological Study

K. Jellinger, W. Grisold, D. Volc, 1993 .

Prevalence of Alzheimer's disease in very elderly people: A prospective neuropathological study. Authors' reply

K. Jellinger, M. Haltia, T. Polvikoski, 2002 .

[Clinical picture, cerebrospinal fluid findings, and pathological anatomy of subacute demyelinating encephalitis ("mixed form" of multiple, diffuse and concentric sclerosis)].

K. Jellinger, U. Traugott, G. Schnaberth, 1976, Der Nervenarzt.

Alzheimer pathology in Parkinson's disease

K. Jellinger, 1989, Neurology.

Mild cognitive impairment in multiple system atrophy: a brain network disorder

K. Jellinger, 2023, Journal of Neural Transmission.

Fundamentals of Functional Brain Imaging. A guide to the methods and their applications to psychology and behavioral neuroscience

K. Jellinger, K. A. Jellinger, 1999 .

Neuro-Oncology: Blue Books of Neurology Series

K. Jellinger, 2011 .

The Space Between Our Ears. How the brain represents visual space

K. Jellinger, K. A. Jellinger, 2006 .